Fig. 4From: The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletionAssociation between SENP1 expression and biochemical recurrence in a) all cancers, b) ERG-IHC positive cancers, c) ERG-IHC negative cancers. Combined effect of SENP1 and PTEN deletion in d) all cancers, e) ERG-IHC positive cancers and f) ERG-IHC negative cancersBack to article page